Cargando…
A Quantitative Systems Pharmacology Model of T Cell Engager Applied to Solid Tumor
Cancer immunotherapy has recently drawn remarkable attention as promising results in the clinic have shown its ability to improve the overall survival, and T cells are considered to be one of the primary effectors for cancer immunotherapy. Enhanced and restored T cell tumoricidal activity has shown...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293198/ https://www.ncbi.nlm.nih.gov/pubmed/32533270 http://dx.doi.org/10.1208/s12248-020-00450-3 |